Shenzen China, March 23 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com is pleased to announce that Mellow Hope a subsidiary of HTDS was granted import licensing from Guatemala's Ministry of Health to import their Oral Poliomyelitis Vaccine (Brand Name: Mevac-OPV). Application has now been made to the Chinese State Food & Drug Administration (FDA) for an export license. Anticipated delivery date for the vaccine is 2nd quarter of 2009.
Terry Yuan HTDS CEO said, "Guatemala's Expanded Vaccination Program (EPI) requires for all newborns to be vaccinated. The OPV is included in this vaccination program. In 2008, the country realized a new birth rate of 380,000. Given these statistics, demand for the Mevac-OPV is expected to be extremely high".
The company will provide further details as they become available.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.
CONTACT: For medical and scientific dialogue inquiry only, please contact Andrea Zecevic Hbsc. Msci; via e-mail at azconsulting2001@gmail.com. Andrea Zecevic obtained her degrees at the University of Toronto Canada. Andrea Zecevic is the company's Chief Project Scientist, R&D and the Chief Liaison Director between the China and Serbia operating subsidiaries.
For any corporate matters, readers should contact the company directly at corporate@htdsmedical.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment